98%
921
2 minutes
20
Hyperbolic materials have emerged as a powerful medium for manipulating polaritons at deeply subwavelength scales. In the realm of polaritonic applications, -MoO/graphene heterostructures have shown great promise, featuring low-loss, electrically tunable negative refraction, and enhanced focusing and steering capabilities. However, a significant challenge has been the manipulation of the focusing position of hybrid polaritons, which is limited to a line perpendicular to the interface or unable to be manipulated while steering. Stacking twisted bilayer -MoO with graphene could provide a potential way to manipulate the steering and focusing position with more flexibility. Here, we demonstrate tunable negative refraction steering of hybrid polaritons within a two-dimensional plane in graphene/twisted bilayer -MoO heterostructures. By modulating the Fermi energy of graphene and adjusting the twist angle of -MoO bilayers, we facilitate the modulation of the focusing position across a two-dimensional plane. This method enables precise tunable directional control of the energy flow within the heterostructures, facilitating a versatile approach to the nanoscale planar focusing of polaritons.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1364/OE.545811 | DOI Listing |
RSC Adv
August 2025
University of Coimbra, CEMMPRE, ARISE, Department of Mechanical Engineering Rua Luís Reis Santos Coimbra 3030-788 Portugal.
This study addresses the growing need for sustainable and multifunctional materials by developing novel polycaprolactone (PCL)/chitosan (CS)/zirconium dioxide (ZrO) nanocomposite films. While PCL and CS offer biocompatibility and biodegradability, their combined use presents limitations for advanced applications requiring specific functional features. The incorporation of ZrO nanoparticles aims to overcome these limitations and create materials with enhanced mechanical, electrical, optical, and antibacterial properties.
View Article and Find Full Text PDFOphthalmic Physiol Opt
September 2025
Centre for Vision and Eye Research, Queensland University of Technology, Brisbane, Queensland, Australia.
Purpose: Few studies have comprehensively investigated the effect of low dose atropine on the binocular vision system beyond accommodative amplitude. This study examined the effect of 0.05% atropine eye drops on a range of accommodation and vergence parameters across a 10-day period.
View Article and Find Full Text PDFBMC Ophthalmol
September 2025
Optometry Center, Shaanxi Key Laboratory of Ophthalmology, Xi'an No.1 Hospital (the First Affiliated Hospital of Northwest University), Shaanxi Institute of Ophthalmology, No.30, Fenxiang Alley, South Street, Xi'an, Shaanxi Province, 710002, China.
Purpose: To determine the baseline ocular biometrics in children with axial length reduction after orthokeratology for better myopia control.
Methods: Changes in ocular parameters in 164 subjects who completed one year of Ortho-K treatment were retrospectively reviewed. The subjects were divided into AL reduction (n = 105, ≤ 0 mm/year axial growth) and AL elongation (n = 59, ≥ 0.
J Optom
August 2025
National Engineering Research Centre of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China; National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China; WEIRC, Wenzhou Medical University-Essilor International Research Centre, Wenzhou M
Purpose: To identify independent risk factors for myopia onset in schoolchildren, with a focus on binocular visual function.
Methods: We conducted a school-based prospective cohort study in Wenzhou, China. Schoolchildren in grades 2 and 3 were recruited in 2014 and followed until graduation at grade 6.
J Optom
August 2025
Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, 18 Zetian Road, Futian District, Shenzhen, 518040, China. Electronic address:
Purpose: To evaluate the efficacy of weekly unilateral application of 1 % atropine on reducing anisometropia in Chinese children with low myopia.
Methods: In this retrospective cohort study, anisometropic children aged 6-12 years receiving atropine in the more myopic eye for at least 3 months were included in atropine group (n = 150), and baseline matched counterparts without atropine use were included in control group (n = 50). Changes in spherical equivalent refraction (SER), axial length (AL) and other biometric parameters between each visits were analyzed.